These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37576611)

  • 21. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Makboul M; Farghaly S; Abdelkawi IF
    Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-polarization optical coherence tomography for early bladder-cancer detection: statistical study.
    Gladkova N; Streltsova O; Zagaynova E; Kiseleva E; Gelikonov V; Gelikonov G; Karabut M; Yunusova K; Evdokimova O
    J Biophotonics; 2011 Aug; 4(7-8):519-32. PubMed ID: 21780300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time- and Spectral-resolved two-photon imaging of healthy bladder mucosa and carcinoma in situ.
    Cicchi R; Crisci A; Cosci A; Nesi G; Kapsokalyvas D; Giancane S; Carini M; Pavone FS
    Opt Express; 2010 Feb; 18(4):3840-9. PubMed ID: 20389394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo optical coherence tomography feasibility for bladder disease.
    Zagaynova EV; Streltsova OS; Gladkova ND; Snopova LB; Gelikonov GV; Feldchtein FI; Morozov A
    J Urol; 2002 Mar; 167(3):1492-6. PubMed ID: 11832776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of urinary bladder mass in CT urography with SPAN.
    Cha K; Hadjiiski L; Chan HP; Cohan RH; Caoili EM; Zhou C
    Med Phys; 2015 Jul; 42(7):4271-84. PubMed ID: 26133625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo bladder imaging with microelectromechanical-systems-based endoscopic spectral domain optical coherence tomography.
    Wang Z; Lee CS; Waltzer WC; Liu J; Xie H; Yuan Z; Pan Y
    J Biomed Opt; 2007; 12(3):034009. PubMed ID: 17614717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of optical coherence tomography for bladder cancer: A systematic review and meta-analysis.
    Xiong YQ; Tan J; Liu YM; Li YZ; You FF; Zhang MY; Chen Q; Zou K; Sun X
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():298-304. PubMed ID: 31185324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Value of Amide Proton Transfer MRI in the Diagnosis of Malignant and Benign Urinary Bladder Lesions: Comparison With Diffusion-Weighted Imaging.
    Li JL; Xu Y; Xiang YS; Wu P; Shen AJ; Wang PJ; Wang F
    J Magn Reson Imaging; 2024 Sep; 60(3):1124-1133. PubMed ID: 38174777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and resection of carcinoma in situ of the bladder: Implications for clinical trial design.
    Roumiguié M; Wong A; Belanger E; Wang G; Black PC
    Urol Oncol; 2023 May; 41(5):254.e9-254.e15. PubMed ID: 36566105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications.
    Cauberg EC; de Bruin DM; Faber DJ; van Leeuwen TG; de la Rosette JJ; de Reijke TM
    Eur Urol; 2009 Aug; 56(2):287-96. PubMed ID: 19285787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa-8 Study.
    Drejer D; Béji S; Oezeke R; Nielsen AM; Høyer S; Bjerklund Johansen TE; Lam GW; Jensen JB
    Urology; 2017 Apr; 102():138-142. PubMed ID: 27894979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of optical coherence tomography imaging to characterize renal neoplasms: limitations in resolution and depth of penetration.
    Linehan JA; Bracamonte ER; Hariri LP; Sokoloff MH; Rice PS; Barton JK; Nguyen MM
    BJU Int; 2011 Dec; 108(11):1820-4. PubMed ID: 21592299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-resolution imaging diagnosis and staging of bladder cancer: comparison between optical coherence tomography and high-frequency ultrasound.
    Yuan Z; Wang Z; Pan R; Liu J; Cohen H; Pan Y
    J Biomed Opt; 2008; 13(5):054007. PubMed ID: 19021387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing the location of carcinoma in situ (CIS) of the urinary bladder using pirarubicin hydrochloride.
    Uchikoba T; Horiuchi K; Oka F; Sato M; Tsuboi N; Ohaki Y; Nishimura T
    Urol Int; 2005; 74(3):235-9. PubMed ID: 15812210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytopathological expression of different types of urothelial carcinoma in situ in urinary bladder washings.
    Demir MA; Ryd W; Aldenborg F; Holmang S
    BJU Int; 2003 Dec; 92(9):906-10. PubMed ID: 14632844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experience in the use of confocal laser endomicroscopy for the diagnosis of bladder papillary tumors].
    Shoaydarov MA; Martov AG; Andronov AS; Dutov SV; Pominalnaya VM
    Urologiia; 2023 May; (2):99-106. PubMed ID: 37401712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
    Gudjónsson S; Bläckberg M; Chebil G; Jahnson S; Olsson H; Bendahl PO; Månsson W; Liedberg F
    BJU Int; 2012 Jul; 110(2 Pt 2):E41-5. PubMed ID: 22035276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art.
    Williamson SR; Montironi R; Lopez-Beltran A; MacLennan GT; Davidson DD; Cheng L
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):112-26. PubMed ID: 20097572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
    Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
    Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.